AmbiCom Announces $1.3 million order for WiFi cards to be used for major manufacturer’s Glucose Meters
Milpitas, CA (May 29, 2012) – AmbiCom Holdings, Inc. (OTCQB:ABHI), a leading designer and developer of wireless products for the medical industry and a distributor of innovative healthcare products, today announced that it has received a $1.3 million order from one of its major medical device customers, for AmbiCom WiFi cards to be used in the manufacturer of this healthcare company’s hospital grade glucose meters. The order is expected to be shipped to the customer by the end of July.
Wireless transmission of medical data is an area that continues to grow both in the United States and internationally. AmbiCom has been a supplier of WiFi cards for this segment of the market for the past six years. This order, in addition to several other potential orders the company is developing, are expected to bring about a turnaround for the company’s business going forward.
About AmbiCom Holdings, Inc.
AmbiCom is headquartered in Milpitas, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company’s wireless modules and devices are based on the Company’s innovative application software for both Wi-Fi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware, and to bringing new and innovative products to the wireless medical markets and other sectors. AmbiCom also serves as a distributor for innovative healthcare products both in the US and abroad. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value. For more information, visit www.ambicom.com
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 18934. Although forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements, including but not limited to, our ability to maintain our website and associated computer systems, our ability to generate sufficient market acceptance for our products and services, our ability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission from time to time which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
Martin E. Janis & Company, Inc.